Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study

Anna Fagotti; Ida Paris; Filomena Grimolizzi; Francesco Fanfani; G Vizzielli; A Naldini; Giovanni Scambia

doi:10.1016/j.ygyno.2009.03.004

Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study

Anna Fagotti
, Ida Paris
, Filomena Grimolizzi
, Francesco Fanfani
, G Vizzielli
, A Naldini
, Giovanni Scambia

Risultato della ricerca: Contributo in rivista › Articolo

50 Citazioni (Scopus)

Abstract

To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer patients.

Lingua originale	Inglese
pagine (da-a)	335-340
Numero di pagine	6
Rivista	Gynecologic Oncology
Volume	113
DOI	https://doi.org/10.1016/j.ygyno.2009.03.004
Stato di pubblicazione	Pubblicato - 2009

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Adult
Antineoplastic Agents
Combined Modality Therapy
Female
Humans
Hyperthermia, Induced
Infusions, Parenteral
Middle Aged
Neoplasm Recurrence, Local
Organoplatinum Compounds
Ovarian Neoplasms
Survival Analysis

Accesso al documento

10.1016/j.ygyno.2009.03.004

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{a7317e3b840447259ba59a789d98b121,

title = "Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study",

abstract = "To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer patients.",

keywords = "Adult, Antineoplastic Agents, Combined Modality Therapy, Female, Humans, Hyperthermia, Induced, Infusions, Parenteral, Middle Aged, Neoplasm Recurrence, Local, Organoplatinum Compounds, Ovarian Neoplasms, Survival Analysis, Adult, Antineoplastic Agents, Combined Modality Therapy, Female, Humans, Hyperthermia, Induced, Infusions, Parenteral, Middle Aged, Neoplasm Recurrence, Local, Organoplatinum Compounds, Ovarian Neoplasms, Survival Analysis",

author = "Anna Fagotti and Ida Paris and Filomena Grimolizzi and Francesco Fanfani and G Vizzielli and A Naldini and Giovanni Scambia",

year = "2009",

doi = "10.1016/j.ygyno.2009.03.004",

language = "English",

volume = "113",

pages = "335--340",

journal = "Gynecologic Oncology",

issn = "1095-6859",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study

AU - Fagotti, Anna

AU - Paris, Ida

AU - Grimolizzi, Filomena

AU - Fanfani, Francesco

AU - Vizzielli, G

AU - Naldini, A

AU - Scambia, Giovanni

PY - 2009

Y1 - 2009

N2 - To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer patients.

AB - To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer patients.

KW - Adult

KW - Antineoplastic Agents

KW - Combined Modality Therapy

KW - Female

KW - Humans

KW - Hyperthermia, Induced

KW - Infusions, Parenteral

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Organoplatinum Compounds

KW - Ovarian Neoplasms

KW - Survival Analysis

KW - Adult

KW - Antineoplastic Agents

KW - Combined Modality Therapy

KW - Female

KW - Humans

KW - Hyperthermia, Induced

KW - Infusions, Parenteral

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Organoplatinum Compounds

KW - Ovarian Neoplasms

KW - Survival Analysis

UR - http://hdl.handle.net/10807/32520

U2 - 10.1016/j.ygyno.2009.03.004

DO - 10.1016/j.ygyno.2009.03.004

M3 - Article

SN - 1095-6859

VL - 113

SP - 335

EP - 340

JO - Gynecologic Oncology

JF - Gynecologic Oncology

ER -

Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo